Natalie M. LaPrade Medical Cannabis Commission – Compassionate Use Fund – Revisions (The Fakiza Rahman Act)
What this bill does
Requiring the Natalie M. LaPrade Medical Cannabis Commission, not the Maryland Department of Health, to administer the Compassionate Use Fund; prohibiting the Commission from imposing certain fees during the two years immediately following the issuance of a license; requiring the Commission to establish a program to allow individuals enrolled in the Maryland Medical Assistance Program or the Veteran Affairs Maryland Health Care System to obtain medical cannabis at a reduced cost; requiring the Commission to set a certain fee structure; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (8)
MGA witness list| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Pena-Melnyk, Delegate Joseline | MGA-Vice Chair HGO | Position only |
| FAV | Pena-Melnyk, Joseline | MGA-Vice Chair HGO | Oral + Written (PDF) |
| FAV | Delegate Pena-Melnyk, Delegate Pena-Melnyklegislator | Individual | Position only |
| FWA | Bryce, Joe | CANMD | Oral |
| FWA | Ye, Webster | MD Dept of Health | Written (PDF) |
| FWA | Bagwell, Ashlielobbyist | MDMDA | Oral |
| FWA | Tilburg, Will | MMCC | Oral |
| FWA | Tilburg, Will | Maryland Medical Cannabis Commission | Oral + Written (PDF) |